Business / Finance

RSS

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.

26 Feb 2014

ViroXis signs agreement with global pharmaceutical for marketing of OTC sandalwood oil-containing product

ViroXis Corporation is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of an over-the-counter (OTC) sandalwood oil-containing product.

26 Feb 2014

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS' sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO).

26 Feb 2014

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.

26 Feb 2014

Quest Diagnostics hosts series of "Tech Talks" and programs during HIMSS 2014

Quest Diagnostics, the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech Talks" and other programs during the HIMSS 2014 Annual Conference & Exhibition, the industry's largest health IT educational program and exhibition February 23 – 27 in Orlando, Florida.

From Quest Diagnostics 26 Feb 2014

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Agilent Technologies Inc. (NYSE:A) and CambTEK, Ltd. today announced an agreement to co-market CambTEK's Rapid Extraction System (RES) automated sample preparation technology with an assortment of Agilent's liquid phase separation, life science and chemical analysis instruments and software.

26 Feb 2014

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced that it has sold $34.6 million of a $39 million Series C equity funding round from existing investors with the lead investment from MedCare Investment Funds.

25 Feb 2014

Healthy Directions launches Krill Omega Defense

Healthy Directions, LLC, today announced the launch of Krill Omega Defense™, a unique krill supplement formulated by Julian Whitaker, MD, that supports and maintains the health of the body's key biological functions and systems—from the heart, brain, and nerves to the eyes and bones.

25 Feb 2014

Toshiba introduces strategy to establish healthcare business

Toshiba Corporation has introduced the strategy that it will promote to establish its healthcare business as a third main pillar of operations, along with its energy and storage businesses.

25 Feb 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

Greatbatch announces results for fourth quarter and full-year ended 2014

Greatbatch, Inc., today announced results for its fourth quarter and full-year ended January 3, 2014 highlighted by 5% constant currency organic revenue growth for the full year 2013; 12% year over year improvement in adjusted operating income; and 19% improvement in adjusted diluted EPS over 2012.

25 Feb 2014

EarlySense partners with Welch Allyn to increase point of care

EarlySense, the market leader in proactive patient care solutions, together with Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, announced today an ongoing strategic partnership.

25 Feb 2014

PDL BioPharma releases fourth quarter and full year 2013 financial results for period ended 2013

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2013 financial results for the period ended December 31, 2013, on Monday, March 3, 2014, after market close.

24 Feb 2014

NHB announces new partnership with 3-time Gold Medalist Kerri Walsh Jennings

In an effort to increase awareness of the multi-faceted benefits of honey, the National Honey Board (NHB) announced a new partnership today with 3-time Gold Medalist Kerri Walsh Jennings, of beach volleyball fame.

24 Feb 2014

Coalfire, HealthShare partner to offer compliance management services to healthcare customers

Coalfire and HealthShare Montana announced today their partnership to offer compliance management services to healthcare-provider customers across the State of Montana.

24 Feb 2014

IIN collaborates with Nanyang Technological University to establish Nanomedicine

Northwestern University's International Institute for Nanotechnology (IIN) is collaborating with Nanyang Technological University (NTU), Singapore, to establish the NTU-Northwestern Institute for Nanomedicine.

24 Feb 2014

UCSF and Samsung partner to accelerate validation of new digital health technologies

Samsung Electronics Co., Ltd., and UC San Francisco (UCSF), one of the world's premier health sciences universities, today announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.

24 Feb 2014

Boston Heart receives $1.0M in additional tax incentives through Life Sciences Tax Incentive Program

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.

21 Feb 2014

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Impax Laboratories, Inc. today reported fourth quarter and full year ended December 31, 2013 results.

21 Feb 2014

XenoPort reports net loss of $19.1 million for fourth quarter 2013

XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.

20 Feb 2014

Business / Finance

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

ViroXis signs agreement with global pharmaceutical for marketing of OTC sandalwood oil-containing product

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

Quest Diagnostics hosts series of "Tech Talks" and programs during HIMSS 2014

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Healthy Directions launches Krill Omega Defense

Toshiba introduces strategy to establish healthcare business

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Greatbatch announces results for fourth quarter and full-year ended 2014

EarlySense partners with Welch Allyn to increase point of care

PDL BioPharma releases fourth quarter and full year 2013 financial results for period ended 2013

NHB announces new partnership with 3-time Gold Medalist Kerri Walsh Jennings

Coalfire, HealthShare partner to offer compliance management services to healthcare customers

IIN collaborates with Nanyang Technological University to establish Nanomedicine

UCSF and Samsung partner to accelerate validation of new digital health technologies

Boston Heart receives $1.0M in additional tax incentives through Life Sciences Tax Incentive Program

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

XenoPort reports net loss of $19.1 million for fourth quarter 2013

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News